UBS Group’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

UBS Group’s Portfolio ISLE Stock Details ISLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,598	Closed	-$46K	–	11719
2022 Q2	$46K	Buy	4,598 +1,979	+76%	+$19.6K	﹤0.01%	5992
2022 Q1	$26K	Buy	+2,619	New	+$25.8K	﹤0.01%	7174
2021 Q4	–	Sell	-66	Closed	-$1K	–	11187
2021 Q3	$1K	Sell	66 -527	-89%	-$5.14K	﹤0.01%	9415
2021 Q2	$6K	Buy	+593	New	+$5.79K	﹤0.01%	8501

UBS Group's ISLE Position: Q3 2022 in Review

UBS Group sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 4,598 shares — an estimated $46K sold.

UBS Group first reported a position in ISLE in Q2 2021 and held it in 4 quarters. The position peaked at $46K in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

UBS Group reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
UBS Group sold 4,598 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $46K.
UBS Group first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q2 2021 and held it in 4 quarters.
UBS Group's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $46K in Q2 2022.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.